As of October 22, 2026, 7-OH (7-Hydroxymitragynine) is illegal to sell at retail in Ohio. 7-OH NAMED Schedule I (OAC 4729:9-1-01.1); mitragynine/leaf exempt. Listed as schedule 1, effective 2025-12-12. Controlling source: OAC 4729:9-1-01.1 Mitragynine-related compounds (permanent, eff. May 19, 2026).
Verified October 22, 2026 (llm review) · confidence: confirmedOAC 4729:9-1-01.1 schedules "Mitragynine-related compounds" incl. 7-hydroxymitragynine and mitragynine pseudoindoxyl as Schedule I; Mitragynine (4) and natural leaf/GRAS/FDA-approved forms exempt.
Among Ohio's 5 neighbors, Indiana and Kentucky are illegal; West Virginia is restricted; Michigan and Pennsylvania are legal.
Open the interactive map · Every compound in Ohio
Not federally scheduled. 7-OH: not yet scheduled; DEA re-noticed Oct 14 (Schedule I above 1 mg/g or under 100:1 mitragynine ratio) on or after Nov 13 Federal detail
1 instrument on file for this compound's framework in Ohio; 1 of 1 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.
629bd14f29d13383The following are classified as schedule I controlled substances: (A) Mitragynine-related compounds, whether synthetic or naturally occurring substances contained in the plant, or in the resinous extractives of mitragyna speciosa (also known as kratom) and/or synthetic substances, derivatives, prodrugs, isomers, esters, ethers, salts and salts of isomers, esters and ethers with similar chemical structure. Mitragynine-related compounds include, but are not limited to, the following: 7-hydroxymitragynine; mitragynine pseudoindoxyl; dihydro-7-hydroxy mitragynine; and 7-acetoxymitragynine. Mitragynine-related compounds do not include any of the following: (1) Any dangerous drug that is the subject of an application approved by the [FDA] under subsections 505(c) or (j) of the [FD&C Act] ... for marketing as a dangerous drug; (2) Any compound used in food consistent with either: (a) A food additive regulation published in the [CFR]; or (b) A "no questions response" issued by the [FDA] in response to a [GRAS] notice. (3) Any drug approved by the [FDA] ... that may be lawfully sold over the counter without a prescription in accordance with section 505G of the [FD&C Act] ...; (4) Mitragynine.
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · Data & API · llms.txt · Sitemap